Europe Mesenchymal Stem Cells Market by Manufacturers, Countries, Type and Application, Forecast to 2022


Report ID : RNR-195657 Category : Biotechnology Published Date : 8/15/2017
Publisher : GlobalInfo Research Pages : 115 Format : PDF
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal.

Scope of the Report:
This report focuses on the Mesenchymal Stem Cells in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
    Lonza
    Thermo Fisher
    Bio-Techne
    ATCC
    MilliporeSigma
    PromoCell GmbH
    Genlantis
    Celprogen
    Cell Applications
    Cyagen Biosciences
    Axol Bioscience

Market Segment by Countries, covering
    Germany
    UK
    France
    Russia
    Italy

Market Segment by Type, covers
    Human MSC
    Mouse MSC
    Rat MSC
    Other

Market Segment by Applications, can be divided into
    Research Institute
    Hospital
    Others

There are 17 Chapters to deeply display the Europe Mesenchymal Stem Cells market.

Chapter 1, to describe Mesenchymal Stem Cells Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Mesenchymal Stem Cells, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Mesenchymal Stem Cells, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications;

Chapter 12, Mesenchymal Stem Cells market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe Mesenchymal Stem Cells sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Mesenchymal Stem Cells Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents
1 Market Overview
    1.1 Mesenchymal Stem Cells Introduction
    1.2 Market Analysis by Type
        1.2.1 Human MSC
        1.2.2 Mouse MSC
        1.2.3 Rat MSC
        1.2.4 Other
    1.3 Market Analysis by Applications
        1.3.1 Research Institute
        1.3.2 Hospital
        1.3.3 Others
    1.4 Market Analysis by Countries
        1.4.1 Germany Status and Prospect (2012-2022)
        1.4.2 France Status and Prospect (2012-2022)
        1.4.3 UK Status and Prospect (2012-2022)
        1.4.4 Russia Status and Prospect (2012-2022)
        1.4.5 Italy Status and Prospect (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Lonza
        2.1.1 Profile
        2.1.2 Mesenchymal Stem Cells Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Lonza Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.1.4 Business Overview
        2.1.5 Lonza News
    2.2 Thermo Fisher
        2.2.1 Profile
        2.2.2 Mesenchymal Stem Cells Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Thermo Fisher Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.2.4 Business Overview
        2.2.5 Thermo Fisher News
    2.3 Bio-Techne
        2.3.1 Profile
        2.3.2 Mesenchymal Stem Cells Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Bio-Techne Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.3.4 Business Overview
        2.3.5 Bio-Techne News
    2.4 ATCC
        2.4.1 Profile
        2.4.2 Mesenchymal Stem Cells Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 ATCC Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.4.4 Business Overview
        2.4.5 ATCC News
    2.5 MilliporeSigma
        2.5.1 Profile
        2.5.2 Mesenchymal Stem Cells Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 MilliporeSigma Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.5.4 Business Overview
        2.5.5 MilliporeSigma News
    2.6 PromoCell GmbH
        2.6.1 Profile
        2.6.2 Mesenchymal Stem Cells Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 PromoCell GmbH Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.6.4 Business Overview
        2.6.5 PromoCell GmbH News
    2.7 Genlantis
        2.7.1 Profile
        2.7.2 Mesenchymal Stem Cells Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 Genlantis Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.7.4 Business Overview
        2.7.5 Genlantis News
    2.8 Celprogen
        2.8.1 Profile
        2.8.2 Mesenchymal Stem Cells Type and Applications
            2.8.2.1 Type 1
            2.8.2.2 Type 2
        2.8.3 Celprogen Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.8.4 Business Overview
        2.8.5 Celprogen News
    2.9 Cell Applications
        2.9.1 Profile
        2.9.2 Mesenchymal Stem Cells Type and Applications
            2.9.2.1 Type 1
            2.9.2.2 Type 2
        2.9.3 Cell Applications Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.9.4 Business Overview
        2.9.5 Cell Applications News
    2.10 Cyagen Biosciences
        2.10.1 Profile
        2.10.2 Mesenchymal Stem Cells Type and Applications
            2.10.2.1 Type 1
            2.10.2.2 Type 2
        2.10.3 Cyagen Biosciences Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.10.4 Business Overview
        2.10.5 Cyagen Biosciences News
    2.11 Axol Bioscience
        2.11.1 Profile
        2.11.2 Mesenchymal Stem Cells Type and Applications
            2.11.2.1 Type 1
            2.11.2.2 Type 2
        2.11.3 Axol Bioscience Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.11.4 Business Overview
        2.11.5 Axol Bioscience News
3 Europe Mesenchymal Stem Cells Market Competition, by Manufacturer
    3.1 Europe Mesenchymal Stem Cells Sales and Market Share by Manufacturer (2016-2017)
    3.2 Europe Mesenchymal Stem Cells Revenue and Market Share by Manufacturer (2016-2017)
    3.3 Europe Mesenchymal Stem Cells Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Mesenchymal Stem Cells Manufacturer Market Share
        3.4.2 Top 5 Mesenchymal Stem Cells Manufacturer Market Share
    3.5 Market Competition Trend
4 Europe Mesenchymal Stem Cells Market Analysis by Countries (2012-2017)
    4.1 Europe Mesenchymal Stem Cells Sales Market Share by Countries (2012-2017)
    4.2 Europe Mesenchymal Stem Cells Sales by Countries (2012-2017)
    4.3 Europe Mesenchymal Stem Cells Revenue (Value) by Countries (2012-2017)
5 Europe Market Segmentation Mesenchymal Stem Cells by Type
    5.1 Europe Mesenchymal Stem Cells Sales, Revenue and Market Share by Type (2012-2017)
        5.1.1 Europe Mesenchymal Stem Cells Sales and Market Share by Type (2012-2017)
        5.1.2 Europe Mesenchymal Stem Cells Revenue and Market Share by Type (2012-2017)
    5.2 Human MSC Sales Growth and Price
        5.2.1 Europe Human MSC Sales Growth (2012-2017)
        5.2.2 Europe Human MSC Price (2012-2017)
    5.3 Mouse MSC Sales Growth and Price
        5.3.1 Europe Mouse MSC Sales Growth (2012-2017)
        5.3.2 Europe Mouse MSC Price (2012-2017)
    5.4 Rat MSC Sales Growth and Price
        5.4.1 Europe Rat MSC Sales Growth (2012-2017)
        5.4.2 Europe Rat MSC Price (2012-2017)
    5.5 Other Sales Growth and Price
        5.5.1 Europe Other Sales Growth (2012-2017)
        5.5.2 Europe Other Price (2012-2017)
6 Europe Market Segmentation Mesenchymal Stem Cells by Application
    6.1 Europe Mesenchymal Stem Cells Sales Market Share by Application (2012-2017)
    6.2 Research Institute Sales Growth (2012-2017)
    6.3 Hospital Sales Growth (2012-2017)
    6.4 Others Sales Growth (2012-2017)
7 Germany Mesenchymal Stem Cells Sales, Revenue, by Type, Application and Manufacturers
    7.1 Germany Mesenchymal Stem Cells Revenue, Sales and Growth Rate (2012-2017)
    7.2 Germany Mesenchymal Stem Cells Sales and Market Share by Type (2012-2017)
    7.3 Germany Mesenchymal Stem Cells Sales by Application (2012-2017)
    7.4 Germany Mesenchymal Stem Cells Sales, Revenue and Market Share by Manufacturer (2016-2017)
        7.4.1 Germany Mesenchymal Stem Cells Sales and Market Share by Manufacturer (2016-2017)
        7.4.2 Germany Mesenchymal Stem Cells Revenue and Market Share by Manufacturer
    7.5 Germany Mesenchymal Stem Cells Export and Import (2012-2017)
8 UK Mesenchymal Stem Cells Sales, Revenue, by Type, Application and Manufacturers
    8.1 UK Mesenchymal Stem Cells Revenue, Sales and Growth Rate (2012-2017)
    8.2 UK Mesenchymal Stem Cells Sales and Market Share by Type (2012-2017)
    8.3 UK Mesenchymal Stem Cells Sales by Application (2012-2017)
    8.4 UK Mesenchymal Stem Cells Sales, Revenue and Market Share by Manufacturer (2016-2017)
        8.4.1 UK Mesenchymal Stem Cells Sales and Market Share by Manufacturer
        8.4.2 UK Mesenchymal Stem Cells Revenue and Market Share by Manufacturer
    8.5 UK Mesenchymal Stem Cells Export and Import (2012-2017)
9 France Mesenchymal Stem Cells Sales, Revenue, by Type, Application and Manufacturers
    9.1 France Mesenchymal Stem Cells Revenue, Sales and Growth Rate (2012-2017)
    9.2 France Mesenchymal Stem Cells Sales and Market Share by Type (2012-2017)
    9.3 France Mesenchymal Stem Cells Sales by Application (2012-2017)
    9.4 France Mesenchymal Stem Cells Sales, Revenue and Market Share by Manufacturer (2016-2017)
        9.4.1 France Mesenchymal Stem Cells Sales and Market Share by Manufacturer
        9.4.2 France Mesenchymal Stem Cells Revenue and Market Share by Manufacturer
    9.5 France Mesenchymal Stem Cells Export and Import (2012-2017)
10 Russia Mesenchymal Stem Cells Sales, Revenue, by Type, Application and Manufacturers
    10.1 Russia Mesenchymal Stem Cells Revenue, Sales and Growth Rate (2012-2017)
    10.2 Russia Mesenchymal Stem Cells Sales and Market Share by Type
    10.3 Russia Mesenchymal Stem Cells Sales by Application (2012-2017)
    10.4 Russia Mesenchymal Stem Cells Sales, Revenue and Market Share by Manufacturer (2016-2017)
        10.4.1 Russia Mesenchymal Stem Cells Sales and Market Share by Manufacturer
        10.4.2 Russia Mesenchymal Stem Cells Revenue and Market Share by Manufacturer
    10.5 Russia Mesenchymal Stem Cells Export and Import (2012-2017)
11 Italy Mesenchymal Stem Cells Sales, Revenue, by Type, Application and Manufacturers
    11.1 Italy Mesenchymal Stem Cells Revenue, Sales and Growth Rate (2012-2017)
    11.2 Italy Mesenchymal Stem Cells Sales and Market Share by Type
    11.3 Italy Mesenchymal Stem Cells Sales by Application (2012-2017)
    11.4 Italy Mesenchymal Stem Cells Sales, Revenue and Market Share by Manufacturer (2016-2017)
        11.4.1 Italy Mesenchymal Stem Cells Sales and Market Share by Manufacturer
        11.4.2 Italy Mesenchymal Stem Cells Revenue and Market Share by Manufacturer
    11.5 Italy Mesenchymal Stem Cells Export and Import (2012-2017)
12 Mesenchymal Stem Cells Market Forecast (2017-2022)
    12.1 Europe Mesenchymal Stem Cells Sales, Revenue and Growth Rate (2017-2022)
    12.2 Mesenchymal Stem Cells Market Forecast by Countries (2017-2022)
        12.2.1 Germany Mesenchymal Stem Cells Sales Forecast (2017-2022)
        12.2.2 UK Mesenchymal Stem Cells Sales Forecast (2017-2022)
        12.2.3 France Mesenchymal Stem Cells Sales Forecast (2017-2022)
        12.2.4 Russia Mesenchymal Stem Cells Sales Forecast (2017-2022)
        12.2.5 Italy Mesenchymal Stem Cells Sales Forecast (2017-2022)
    12.3 Mesenchymal Stem Cells Market Forecast by Type (2017-2022)
    12.4 Mesenchymal Stem Cells Market Forecast by Application (2017-2022)
13 Mesenchymal Stem Cells Manufacturing Cost Analysis
    13.1 Mesenchymal Stem Cells Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Price Trend of Key Raw Materials
        13.1.3 Key Suppliers of Raw Materials
        13.1.4 Market Concentration Rate of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
        13.2.1 Raw Materials
        13.2.2 Labor Cost
        13.2.3 Manufacturing Expenses
    13.3 Manufacturing Process Analysis of Mesenchymal Stem Cells
14 Industrial Chain, Sourcing Strategy and Downstream Buyers
    14.1 Mesenchymal Stem Cells Industrial Chain Analysis
    14.2 Upstream Raw Materials Sourcing
    14.3 Raw Materials Sources of Mesenchymal Stem Cells Major Manufacturers in 2015
    14.4 Downstream Buyers
15 Sales Channel, Distributors, Traders and Dealers
    15.1 Sales Channel
        15.1.1 Direct Marketing
        15.1.2 Indirect Marketing
        15.1.3 Marketing Channel Future Trend
    15.2 Distributors, Traders and Dealers
16 Research Findings and Conclusion
17 Appendix
    17.1 Methodology
    17.2 Analyst Introduction
    17.3 Data Source